Translational Development... (TDACU)
10.19
0.00 (0.02%)
At close: Mar 25, 2025, 9:34 AM
10.11
-0.77%
Pre-market: Mar 28, 2025, 07:00 AM EDT
Company Description
Trident Acquisitions Corp. is a shell company.
The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.
The Company focuses on identifying a business to a particular industry or geographic region of the world.
The Company is focused on seeking business combination with oil and gas or other natural resources companies in Eastern Europe.
The Company is not engaged in any business operations.
Translational Development Acquisition Corp.
| Country | United States |
| IPO Date | Jan 31, 2022 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Michael M. B. Hoffman J.D. |
Contact Details
Address: 77 Water Street New York, New York United States | |
| Website | http://www.tridentacquisitions.com |
Stock Details
| Ticker Symbol | TDACU |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001673481 |
| CUSIP Number | 89615T205 |
| ISIN Number | US89615T2050 |
| Employer ID | 81-1996183 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Michael M. B. Hoffman J.D. | Chairman of the Board & Chief Executive Officer |
| Avi C. Das | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 26, 2025 | 4 | Filing |
| Mar 11, 2025 | 8-K | Current Report |
| Mar 07, 2025 | 8-K | Current Report |
| Mar 03, 2025 | 4 | Filing |
| Feb 26, 2025 | 4 | Filing |
| Feb 25, 2025 | 144 | Filing |
| Feb 25, 2025 | 144 | Filing |
| Feb 24, 2025 | 8-K | Current Report |
| Feb 14, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G | Filing |